Immunology of Infectious Disease News Volume 11.07 | Feb 22 2023

    0
    16








    2023-02-22 | IIDN 11.07


    Immunology of Infectious Disease News by STEMCELL Technologies
    Vol. 11.07 – 22 February, 2023
    TOP STORY

    The Alarmin Interleukin-33 Promotes the Expansion and Preserves the Stemness of Tcf-1+ CD8+ T Cells in Chronic Viral Infection

    Studying CD8+ T cell differentiation in mice with chronic viral infection, the authors identified the alarmin interleukin-33 as pivotal for the expansion and stem-like functioning of stem-like CD8+ T cells, as well as for virus control.
    [Immunity]

    Full ArticleGraphical Abstract
    ON777CS-HowtoOrganize_728x90
    PUBLICATIONSRanked by the impact factor of the journal

    The Impacts of SARS-CoV-2 Vaccine Dose Separation and Targeting on the COVID-19 Epidemic in England

    Scientists re-examinerd public health recommendations regarding the COVID-19 vaccine target groups and timing of the doses, through a mathematical model of SARS-CoV-2 infection in England.
    [Nature Communications]

    Full Article

    Distinct Tissue Niches Direct Lung Immunopathology via CCL18 and CCL21 in Severe COVID-19

    Researchers combined advanced imaging and spatial transcriptomics to shed light on the local immune response in severe COVID-19, and showed that activated adventitial niches are crucial microenvironments contributing to the orchestration of prolonged lung immunopathology.
    [Nature Communications]

    Full Article

    Cell-Autonomous Requirement for ACE2 across Organs in Lethal Mouse SARS-CoV-2 Infection

    Investigators reported humanized ACE2-floxed mice in which hACE2 was expressed in a manner that confered lethal disease and permitted cell-specific, Cre-mediated loss of function, and LSL-hACE2 mice in which hACE2 was expressed enabling cell-specific, Cre-mediated gain of function.
    [Plos Biology]

    Full Article

    Antiretroviral Therapy Reveals Triphasic Decay of Intact SIV Genomes and Persistence of Ancestral Variants

    Scientists evaluated the frequency of simian immunodeficiency virus (SIV)-infected cells for four years of antiretroviral therapy (ART). The intact proviral DNA assay and an assay for hypermutated proviruses revealed short- and long-term infected cell dynamics in macaques starting ART ∼one year after infection.
    [Cell Host & Microbe]

    Full ArticleGraphical Abstract

    Potent Targeted Activator of Cell Kill Molecules Eliminate Cells Expressing HIV-1

    The authors found bifunctional compounds with HIV-1–infected cell kill potency at clinically achievable concentrations. These targeted activator of cell kill molecules resulted in HIV-1+ cell death through premature intracellular viral protease activation.
    [Science Translational Medicine]

    Abstract

    Mitoxantrone Targets Both Host and Bacteria to Overcome Vancomycin Resistance in Enterococcus faecalis

    Scientists investigated the antibiotic and immunological activity of the anticancer agent mitoxantrone in vitro and in vivo against vancomycin-resistant Enterococcus faecalis.
    [Science Advances]

    Full Article

    Virulence Differences of Mpox (Monkeypox) Virus Clades I, IIa, and IIb.1 in a Small Animal Model

    Researchers demonstrated that the wild-derived inbred castaneous mouse provided an exceptional animal model for investigating clade differences in mpox virus virulence, and showed that the order is clade I > clade IIa > clade IIb.1.
    [Proceedings Of The National Academy Of Sciences Of The United States Of America]

    AbstractPress Release

    Effects of Adjuvants in a Rabies-Vectored Ebola Virus Vaccine on Protection from Surrogate Challenge

    The authors demonstrated that toll-like receptor 4 agonist Glucopyranosyl lipid adjuvant in a squalene oil-in-water emulsion improved inactivated, bivalent filovirus/rabies virus vaccine efficacy in a murine model by activating the innate immune system and shaping a Th1-biased adaptive immune response.
    [Npj Vaccines]

    Full Article
    Activate, expand, and differentiate your cells with cytokines, chemokines, and growth factors from STEMCELL Technologies.
    REVIEWS

    Past SARS-CoV-2 Infection Protection against Re-Infection: A Systematic Review and Meta-Analysis

    The authors identified, reviewed, and extracted from the scientific literature retrospective and prospective cohort studies and test-negative case-control studies published from inception up to Sept 31, 2022, that estimated the reduction in risk of COVID-19 among individuals with a past SARS-CoV-2 infection in comparison to those without a previous infection.
    [Lancet]

    Full ArticlePress Release
    INDUSTRY AND POLICY NEWS

    Third Patient Free of HIV after Receiving Virus-Resistant Cells

    A 53-year-old man in Germany has become at least the third person with HIV to be declared clear of the virus after a procedure that replaced his bone marrow cells with HIV-resistant stem cells from a donor.
    [Nature News]

    News Article

    BU Researchers Join $100 Million Effort to Fight Future Deadly Pathogens

    The Howard Hughes Medical Institute’s Emerging Pathogens Initiative, which is pulling in 70 scientists from 29 organizations, will include seven Boston University (BU) researchers, who will be part of teams working on the next generation of RNA-based antiviral therapies and investigating microscopic pathogenic parasites called protozoa.
    [The Brink (Boston University)]

    Press Release
    FEATURED EVENT

    Fibrosis Pathogenesis and Resolution: From Mechanisms to Therapies

    March 19 – 23, 2023
    Banff, Alberta, Canada

    > See All Events

    JOB OPPORTUNITIES

    Research Officer – Bioinformatics

    The University of Melbourne – Melbourne, Australia

    Postdoctoral Position – Hepatitis C Virus Vaccine Research

    Twincore GmbH – Hannover, Germany

    PhD Position – Infection Immunology

    Helmholtz Centre for Infection Research – Braunschweig, Germany

    Full Professorship – Immunology

    The University of Konstanz – Konstanz, Germany

    Group Leader – Virology

    The University of Edinburgh – Edinburgh, Scotland, United Kingdom

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Immunology of Infectious Disease News Twitter